You are here: Industry Insights > Upsa

News List

Taisho Pharmaceutical concludes acquisition of UPSA pharmaceutical-technology
July 03, 2019
Taisho Pharmaceutical has completed an acquisition of Bristol-Myers Squibb’s (BMS) UPSA consumer health business, further supporting its self-medication franchise.
BMS receives offer from Taisho to purchase UPSA cphi-online
January 02, 2019
The potential transaction would position BMS to further refine its portfolio to focus on transformational medicines for patients facing serious diseases.
Bristol-Myers Squibb Announces Offer from Taisho Pharmaceutical to Purchase UPSA americanpharmaceuticalreview
December 24, 2018
Bristol-Myers Squibb announced that Taisho Pharmaceutical has offered to purchase Bristol-Myers Squibb’s UPSA consumer health business for $1.6 billion....
BMS confirms Taisho’s $1.6bn offer for UPSA pharmaphorum
December 21, 2018
After protracted speculation, Bristol-Myers Squibb has confirmed it plans to divest its French over-the-counter (OTC) medicines business UPSA to Japan’s Taisho Pharma in a $1.6 billion deal.
Japan’s Taisho offers to acquire Bristol-Myer’s UPSA for $1.6bn pharmaceutical-technology
December 21, 2018
Japan-based Taisho Pharmaceutical has offered to acquire US-based Bristol-Myers Squibb’s UPSA consumer health business for $1.6bn.....
Bristol-Myers Squibb looks to sell French OTC unit which could bring $1.8B fiercepharma
July 09, 2018
Add Bristol-Myers Squibb to the list of Big Pharmas doing consumer health reevaluations these days. After announcing a review last month, the U.S. drugmaker is looking to sell its French consumer health business, Upsa, according to Reuters.